AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1869364
Drug: Albendazole 800
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole 800 mg x 3 days
Trial: 1869364
Drug: Albendazole 800
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole 800 mg x 2 days
Trial: 1869364
Drug: Albendazole 400
RxNorm normalized name: albendazole 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole 400 mg x 1 day
Trial: 15641626
Drug: Once-daily budesonide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily budesonide administration
Trial: 7707626
Drug: Monovalent vaccine
RxNorm normalized name: rotavirus, live, monovalent vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent vaccine
Trial: 7704169
Drug: Tetravalent vaccine
RxNorm normalized name: DENGUE TETRAVALENT VACCINE,LIVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetravalent vaccine
Trial: 28340572
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (0.5 mg/kg, maximum 20 mg) and oral ketamine (3 mg/kg, maximum 50 mg) with 100% oxygen (MK)
Trial: 28340572
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (0.5 mg/kg, maximum 20 mg) and oral ketamine (3 mg/kg, maximum 50 mg) with inhalational sevoflurane at a sedative dose (MKS)
Trial: 23109026
Drug: Placebo (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (5 ml of normal saline via intravenous route)
Trial: 17405800
Drug: Intravitreal triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal triamcinolone (IVTA) injections
Trial: 15082356
Drug: Patient controlled
RxNorm normalized name: PATIENT CONTROLLED ANALGESIA VIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient controlled intranasal (PCIN) fentanyl
Trial: 22268365
Drug: Irbesartan 600
RxNorm normalized name: Irbesartan
DrugBank: Irbesartan (DB01029)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Irbesartan 600 mg
Trial: 22268365
Drug: Irbesartan 900
RxNorm normalized name: Irbesartan
DrugBank: Irbesartan (DB01029)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Irbesartan 900 mg
Trial: 26115880
Drug: LITE condition
RxNorm normalized name: Lite 'N Foamy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LITE condition (one tai chi session twice weekly for 12 weeks)
Trial: 26115880
Drug: PLUS condition
RxNorm normalized name: Dermarest Psoriasis Shampoo Plus Conditioner
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PLUS condition (one tai chi session 3 times weekly for 12 weeks, followed by maintenance classes 1-2 times weekly for an additional 12 weeks)
Trial: 24586994
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of rosuvastatin
Trial: 16950182
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of atorvastatin
Trial: 8339135
Drug: Intermittent D-penicillamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent D-penicillamine therapy (250-750mg daily reduced to the same dose taken 1 week out of every 4)
Trial: 8339135
Drug: Continuous D-penicillamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous D-penicillamine therapy
Trial: 3522630
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral self-control therapy (adjunctive therapy)
Trial: 3522630
Drug: Stimulant medications
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulant medications (standard treatment)
Trial: 29901369
Drug: DMPA (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMPA (150 mg injections)
Trial: 29901369
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no DMPA injection)
Trial: 16410276
Drug: Modified intensified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified intensified insulin therapy (MII) using insulin pens and premixed insulin (30/70, 40/60, 50/50) in Group AI and Group AII.
Trial: 16410276
Drug: Conventional insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional insulin therapy in Group B.
Trial: 12838216
Drug: Prednisone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (40 mg) administered orally 15 hours and 3 hours before ERCP
Trial: 28233458
Drug: β-blocker treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β-blocker treatment
Trial: 11447078
Drug: 450 mL
RxNorm normalized name: ALCOHOL 270 mL in 450 mL EXTRACORPOREAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 450 mL black tea
Trial: 11447078
Drug: 900 mL
RxNorm normalized name: OXYGEN 900 mL in 1 L RESPIRATORY (INHALATION) GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mL black tea daily for 4 weeks
Trial: 9508353
Drug: Intravenous Ferrum
RxNorm normalized name: Ferrum
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous Ferrum Hausmann (iron dextrin)
Trial: 8293316
Drug: 100 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/kg tyrosine
Trial: 31978591
Drug: Hydrogel rectal
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrogel rectal spacer
Trial: 26022239
Drug: High-dose cytarabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cytarabine
Trial: 21689356
Drug: Preoperative mechanical
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative mechanical bowel preparation (4 l of polyethylene glycol) plus a glycerine 5% enema (2 l)
Trial: 21689356
Drug: Single glycerine
RxNorm normalized name: Glycerin
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single glycerine 5% enema (2 l)
Trial: 18087660
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg risedronate on two consecutive days each month (2CDM)
Trial: 18087660
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg daily risedronate
Trial: 17078437
Drug: Acupuncture at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture at the Back‐Shu and Front‐Mu points plus oral decoction
Trial: 17078437
Drug: Oral decoction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral decoction alone
Trial: 30106253
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg escitalopram
Trial: 15274173
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg escitalopram
Trial: 15274173
Drug: All active
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All active treatments (5 mg, 10 mg, 20 mg escitalopram and 20 mg paroxetine)
Trial: 15274173
Drug: Escitalopram (5-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (5-20 mg)
Trial: 11400897
Drug: High-energy extracorporeal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-energy extracorporeal shock wave therapy (Group II)
Trial: 9003206
Drug: Salmeterol, 50
RxNorm normalized name: Fluticasone-Salmeterol, 500 mcg-50 mcg/inh inhalation powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol, 50 micrograms twice daily
Trial: 2892258
Drug: nizatidine 150
RxNorm normalized name: nizatidine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nizatidine 150 mg B.D.
Trial: 19591515
Drug: Clozapine ODT
RxNorm normalized name: Clozapine Orally Disintegrating Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine ODT 12.5 mg administered after a high-fat/calorie breakfast
Trial: 19591515
Drug: Clozapine ODT
RxNorm normalized name: Clozapine Orally Disintegrating Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine ODT 12.5 mg administered in a fasted state
Trial: 14566480
Drug: Moist skin
RxNorm normalized name: Moist Skin 12% Topical Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moist skin care with 3% urea lotion
Trial: 29035942
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment with bilateral application of diagnostic levels of ultrasound energy
Trial: 8305322
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment applied twice daily
Trial: 3194866
Drug: Prednisone 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 12.5 mg daily
Trial: 25906818
Drug: Sodium-restricted diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium-restricted diet (maximum intake of 3 g of sodium per day)
Trial: 25906818
Drug: Diuretic (spironolactone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic (spironolactone plus furosemide)
Trial: 22803688
Drug: GSK2190915 (50-1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK2190915 (50-1000 mg single doses; 10-450 mg multiple doses; 10-200 mg in crossover design)
Trial: 22803688
Drug: GSK2190915 (≥50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK2190915 (≥50 mg)
Trial: 22803688
Drug: GSK2190915 (≥150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK2190915 (≥150 mg)
Trial: 18289576
Drug: 100 to
RxNorm normalized name: Zionodil 100 Topical Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 to 120 mg bacillus Calmette‐Guerin alone
Trial: 16688994
Drug: Medopa orally,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medopa orally, 125 mg 3 times/day for mild, 250 mg 3 times/day for moderate, and 250 mg 4 times/day for severe cases, for 6 weeks.
Trial: 9797484
Drug: Raloxifene 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 120 mg/day (RLX120)
Trial: 9797484
Drug: Raloxifene 60
RxNorm normalized name: raloxifene 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 60 mg/day (RLX60)
Trial: 1382915
Drug: Lysine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lysine infusion (3-6 g of lysine intravenously followed by 0.3-1.9 g of lysine/kg over 1 hour)
Trial: 18035202
Drug: IM IFN‐betala
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM IFN‐betala 30 microg QW (low-dose)
Trial: 18035202
Drug: SC IFN‐beta1a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC IFN‐beta1a 44 microg TIW (high-dose)
Trial: 16253344
Drug: Divalproex sodium
RxNorm normalized name: Divalproex Sodium
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divalproex sodium (500-2500 mg/day)
Trial: 26137537
Drug: Oral artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral artesunate
Trial: 10078713
Drug: Eptastigmine 15
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Eptastigmine 15 mg three times daily
Trial: 10078713
Drug: Eptastigmine 20
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Eptastigmine 20 mg three times daily
Trial: 8545144
Drug: Ibuprofen (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (3 x 400 mg)
Trial: 8545144
Drug: Ibuprofen (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (3 x 400 mg and 3 x 800 mg)
Trial: 10155349
Drug: Carvedilol (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (25 mg once daily)
Trial: 1974509
Drug: Labetalol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (200 mg twice daily)
Trial: 6112925
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 1 g cephaloridine injected intravenously at the start of operations
Trial: 6112925
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 1 g cephaloridine instilled into the incision at the end of operations
Trial: 27208499
Drug: Propofol (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (0.8 mg/kg)
Trial: 29070709
Drug: NP-BEEF diet
RxNorm normalized name: Beef
DrugBank: Beef (DB10509)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NP-BEEF diet (48 g protein/d)
Trial: 25168659
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (high-dose glimepiride)
Trial: 19926054
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) plus intravenous sodium bicarbonate (NaHCO3)
Trial: 17143601
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg AZD5438
Trial: 17143601
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg AZD5438
Trial: 24417069
Drug: Ascoril expectorant
RxNorm normalized name: ascorbate
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascoril expectorant (Glenmark) at a standard dose
Trial: 21482606
Drug: Nonsurgical periodontitis
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nonsurgical periodontitis treatment before 21 weeks' gestation
Trial: 9568411
Drug: Laceran 10%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laceran 10% urea lotion
Trial: 9568411
Drug: Urea-free Laceran
RxNorm normalized name: Urea
DrugBank: Urea (DB03904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urea-free Laceran lotion base
Trial: 2468300
Drug: Isovolemic hemodilution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isovolemic hemodilution with 500 mL of 10% hydroxyethyl starch 200
Trial: 193642
Drug: POCC (procarbazine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: POCC (procarbazine, 100 mg/m2/day orally, Days 1‐14; vincristine, 2 mg iv, Days 1 and 8; cyclophosphamide, 600 mg/m2 iv, Days 1 and 8; and CCNU, 60 mg/m2 orally, Day 1)
Trial: 193642
Drug: COM (cyclophosphamide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COM (cyclophosphamide, 2000 mg/m2 iv, Day 1; vincristine, 2 mg iv, Day 1; and methotrexate, 30 mg/m2 iv, Day 15)
Trial: 11798687
Drug: Xuezhikang 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xuezhikang 1.2 g/d Bid, p.o
Trial: 11798687
Drug: gemfibrozil 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemfibrozil 1.2 g/d Bid, p.o
Trial: 19304472
Drug: Dual endothelin
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual endothelin receptor antagonists (ERAs)
Trial: 19304472
Drug: Selective endothelin
RxNorm normalized name: endothelial growth factor A, vascular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective endothelin receptor antagonists (ERAs)
Trial: 19304472
Drug: Various endothelin
RxNorm normalized name: endothelial growth factor A, vascular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various endothelin receptor antagonists (ERAs)
Trial: 7884615
Drug: D-penicillamine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-penicillamine therapy (20 mg/kg/day)
Trial: 1679981
Drug: Albuterol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (200 micrograms)
Trial: 26374625
Drug: Prasugrel 10
RxNorm normalized name: prasugrel 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 10 mg maintenance dose
Trial: 26374625
Drug: Prasugrel 5
RxNorm normalized name: prasugrel 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 5 mg maintenance dose
Trial: 12757072
Drug: Fluconazole 600
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 600 mg/day
Trial: 1857478
Drug: Dipyridamole (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole (300 mg/day)
Trial: 21349928
Drug: Indacaterol, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol, 150 μg once daily
Trial: 21349928
Drug: Indacaterol, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol, 300 μg once daily
Trial: 17898337
Drug: Restoration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restoration of dopamine agonist dosage
Trial: 11499564
Drug: Methylprednisolone 1-g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 1-g i.v. for three days at months 1, 3, and 5, plus oral prednisone (0.5 mg/kg every other day for six months)
Trial: 11360502
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g intravenous ceftriaxone once a day (group A)
Trial: 11360502
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g intravenous cefotaxime three times a day (group B)
Trial: 11360502
Drug: 2.25 g
RxNorm normalized name: Zosyn 2.25 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.25 g intravenous cefuroxime three times a day (group C)
Trial: 7869314
Drug: sulfasalazine treatment
RxNorm normalized name: Sulfasalazine
DrugBank: Sulfasalazine (DB00795)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sulfasalazine treatment
Trial: 25810045
Drug: Intralesional corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional corticosteroid therapy repeated every 4 weeks for six sessions (group A)
Trial: 23677811
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg ESL (to-be-marketed formulation)
Trial: 23677811
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg ESL (to-be-marketed formulation)
Trial: 23677811
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg ESL (marketed formulation)
Trial: 23677811
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg ESL (marketed formulation)
Trial: 21367950
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg Fe + folic acid (IFA)
Trial: 21367950
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg Fe + folic acid + 13 micronutrients (UNIMMAP)
Trial: 15493566
Drug: Continuous, low-level,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous, low-level, topical heat wrap therapy
Trial: 26379122
Drug: Mindfulness-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based cognitive therapy with support to taper and/or discontinue antidepressant medication (MBCT-TS)
Trial: 19045965
Drug: Maintenance antidepressant
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance antidepressant medication (m-ADM)
Trial: 15179168
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose ATP (225 mg)
Trial: 15179168
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose ATP (150 mg)
Trial: 11837981
Drug: 3.4 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.4 g/d of highly concentrated very long chain n‐3 PUFA after CABG
Trial: 11837981
Drug: Very long
RxNorm normalized name: Very long chain fatty acyl-CoA synthase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very long chain n‐3 PUFA 5.1-8.0 g/d after PTCA
Trial: 11837981
Drug: 3.4-5.7 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.4-5.7 g/d of very long chain n‐3 PUFA after heart transplantation
Trial: 11837981
Drug: 5.1 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.1 g/d of very long chain n‐3 PUFA
Trial: 3818036
Drug: Aerua lanata
RxNorm normalized name: Krascheninnikovia lanata pollen
DrugBank: Krascheninnikovia lanata pollen (DB10946)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerua lanata extract (200 ml of 50 g/L)
Trial: 3818036
Drug: Aerua lanata
RxNorm normalized name: Krascheninnikovia lanata pollen
DrugBank: Krascheninnikovia lanata pollen (DB10946)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerua lanata extract (100 g/L)
Trial: 26244949
Drug: Enteral paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteral paracetamol (15mg/kg/dose 6 hourly for 7 days)
Trial: 21340182
Drug: Low-intensity ultrasound
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-intensity ultrasound therapy (LIUST)
Trial: 10332320
Drug: Diazepam plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam plus ibuprofen
Trial: 8335426
Drug: Pravastatin 20
RxNorm normalized name: pravastatin 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 20 mg administered twice daily with meals
Trial: 8335426
Drug: Pravastatin 20
RxNorm normalized name: pravastatin 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 20 mg administered twice daily one hour before meals
Trial: 26429963
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium
Trial: 24797294
Drug: Antimicrobial treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial treatment
Trial: 21562484
Drug: Pindolol 20
RxNorm normalized name: pindolol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 20 mg - Placebo
Trial: 19447800
Drug: Sivelestat (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sivelestat (0.3 mg/kg/h intravenous)